Back
Amicus Therapeutics Stock Price Chart
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Sell
24
FOLD
Amicus Therapeutics
Last Price:
10.56
Seasonality Move:
12.34%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.88 | Sell |
| 20-day SMA: | 11.3 | Sell |
| 50-day SMA: | 12.25 | Sell |
| 200-day SMA: | 12.26 | Sell |
| 8-day EMA: | 10.79 | Sell |
| 20-day EMA: | 11.25 | Sell |
| 50-day EMA: | 11.85 | Sell |
| 200-day EMA: | 12.12 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 27.61 | Sell |
| Chaikin Money Flow: | -987778 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.93 - 11.83) | Sell |
| Bollinger Bands (100): | (11.34 - 13.46) | Sell |
Amicus Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 10.34 while FOLD 8-day simple moving average is 10.88, which is a Sell signal.
- The stock price of FOLD is 10.34 while Amicus Therapeutics 20-day SMA is 11.30, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 12.25 while FOLD share price is 10.34, making it a Sell technically.
- FOLD stock price is 10.34 and Amicus Therapeutics 200-day simple moving average is 12.26, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
24
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $10.34. The Score for FOLD is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
3.05B
Price in USD:
10.34
Share Volume:
1.16M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.70
Sell
24
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 10.34 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 10.34 while FOLD 8-day exponential moving average is 10.79, which is a Sell signal.
- The stock price of FOLD is 10.34 while Amicus Therapeutics 20-day EMA is 11.25, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 11.85 while FOLD share price is 10.34, making it a Sell technically.
- FOLD stock price is 10.34 and Amicus Therapeutics 200-day simple moving average is 12.12, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.50 per share, and an increase next year of $0.38 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.45, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 27.61, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (10.93 - 11.83), which suggest Amicus Therapeutics is a Sell
- The Bollinger Bands (100) for Amicus Therapeutics is (11.34 - 13.46), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.